Literature DB >> 7511386

Cysteine 17 of recombinant human granulocyte-colony stimulating factor is partially solvent-exposed.

T Arakawa1, S J Prestrelski, L O Narhi, T C Boone, W C Kenney.   

Abstract

Oh-eda et al. have shown instability of granulocyte-colony stimulating factor (G-CSF) upon storage above pH 7.0 [J. Biol. Chem. (1990) 265, 11,432-11,435]. To clarify the mechanism of this instability, the accessibility of a free cysteinyl residue at position 17 for disulfide exchange reaction was examined using a sulfhydryl reagent. The results show that the cysteine is partially solvent-exposed in both glycosylated and nonglycosylated forms, suggesting that the exposure of the cysteine plays a critical role in the instability of the protein. This is supported by the facts that at low pH where the cysteine is protonated, both proteins have much greater stability and that a Cys17-->Ser analog is extremely stable at neutral pH and 37 degrees C. It was observed that the rate of sulfhydryl titration is slower for the glycosylated form than for the nonglycosylated form, suggesting that the cysteine residue is less solvent-exposed for the former protein or that the pKa is somewhat more basic. In either case, the carbohydrate appears to affect the reactivity of the sulfhydryl group through steric hindrance or alteration in local conformation. Both the glycosylated and nonglycosylated proteins showed essentially identical conformation as determined by circular dichroism, fluorescence, and infrared spectroscopy. Unfolding of these two proteins, induced either by guanidine hydrochloride or by pH, showed an identical course, indicating comparable conformational stability. Contribution of conformational changes to the observed instability at higher pH is unlikely, since little difference in fluorescence spectrum occurs between pH 6.0 and 8.0.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7511386     DOI: 10.1007/bf01025117

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  20 in total

1.  Structure, stability, and receptor interaction of cholera toxin as studied by Fourier-transform infrared spectroscopy.

Authors:  W K Surewicz; J J Leddy; H H Mantsch
Journal:  Biochemistry       Date:  1990-09-04       Impact factor: 3.162

Review 2.  Conformational stability of globular proteins.

Authors:  C N Pace
Journal:  Trends Biochem Sci       Date:  1990-01       Impact factor: 13.807

3.  Infrared spectroscopic discrimination between alpha- and 3(10)-helices in globular proteins. Reexamination of Amide I infrared bands of alpha-lactalbumin and their assignment to secondary structures.

Authors:  S J Prestrelski; D M Byler; M P Thompson
Journal:  Int J Pept Protein Res       Date:  1991-06

4.  Comparison of various molecular forms of bovine trypsin: correlation of infrared spectra with X-ray crystal structures.

Authors:  S J Prestrelski; D M Byler; M N Liebman
Journal:  Biochemistry       Date:  1991-01-08       Impact factor: 3.162

5.  Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor.

Authors:  H S Lu; T C Boone; L M Souza; P H Lai
Journal:  Arch Biochem Biophys       Date:  1989-01       Impact factor: 4.013

6.  Examination of the secondary structure of proteins by deconvolved FTIR spectra.

Authors:  D M Byler; H Susi
Journal:  Biopolymers       Date:  1986-03       Impact factor: 2.505

7.  Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide.

Authors:  S Kitagawa; A Yuo; L M Souza; M Saito; Y Miura; F Takaku
Journal:  Biochem Biophys Res Commun       Date:  1987-05-14       Impact factor: 3.575

8.  Structural characterization of natural and recombinant human granulocyte colony-stimulating factors.

Authors:  N Kubota; T Orita; K Hattori; M Oh-eda; N Ochi; T Yamazaki
Journal:  J Biochem       Date:  1990-03       Impact factor: 3.387

9.  Recombinant human granulocyte colony stimulating factor: molecular and biological characterization.

Authors:  K M Zsebo; A M Cohen; D C Murdock; T C Boone; H Inoue; V R Chazin; D Hines; L M Souza
Journal:  Immunobiology       Date:  1986-09       Impact factor: 3.144

10.  Solvent denaturation of proteins as observed by resolution-enhanced Fourier transform infrared spectroscopy.

Authors:  J M Purcell; H Susi
Journal:  J Biochem Biophys Methods       Date:  1984-07
View more
  16 in total

Review 1.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

2.  Monitoring Effects of Excipients, Formulation Parameters and Mutations on the High Order Structure of Filgrastim by NMR.

Authors:  Yves Aubin; Derek J Hodgson; William B Thach; Geneviève Gingras; Simon Sauvé
Journal:  Pharm Res       Date:  2015-06-05       Impact factor: 4.200

3.  Site-Specific Protein PEGylation: Application to Cysteine Analogs of Recombinant Human Granulocyte Colony-Stimulating Factor.

Authors:  Mary S Rosendahl; Daniel H Doherty; Darin J Smith; Alison M Bendele; George N Cox
Journal:  Bioprocess Int       Date:  2005-04

4.  Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state.

Authors:  Stephen W Raso; Jeff Abel; Jesse M Barnes; Kevin M Maloney; Gary Pipes; Michael J Treuheit; Jonathan King; David N Brems
Journal:  Protein Sci       Date:  2005-09       Impact factor: 6.725

5.  Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected Peptides.

Authors:  Andrew G Roberts; Eric V Johnston; Jae-Hung Shieh; Joseph P Sondey; Ronald C Hendrickson; Malcolm A S Moore; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2015-10-01       Impact factor: 15.419

6.  Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.

Authors:  A Hüttmann; K Schirsafi; S Seeber; P Bojko
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-03       Impact factor: 4.553

7.  Optimization and applications of CDAP labeling for the assignment of cysteines.

Authors:  Gary D Pipes; Andrew A Kosky; Jeffrey Abel; Yu Zhang; Michael J Treuheit; Gerd R Kleemann
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

8.  Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy.

Authors:  Yulong Zhang; Omar Velasco; Xinli Zhang; Kang Ting; Chia Soo; Benjamin M Wu
Journal:  Biomaterials       Date:  2014-05-10       Impact factor: 12.479

Review 9.  Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?

Authors:  M Höglund
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

Review 10.  Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor.

Authors:  Tara Arvedson; James O'Kelly; Bing-Bing Yang
Journal:  BioDrugs       Date:  2015-06       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.